Closing the Daily Disposable Gap in Presbyopic Astigmatism
New multifocal toric daily disposable lens highlights a broader shift in how the profession is approaching one of its most complex – and common – patient groups
As populations age, the dual challenge of managing astigmatism and presbyopia in patients has been increasingly pressing, with nearly half of patients affected by astigmatism and presbyopia projected to impact up to 2.1 billion people by 2030. The recent UK and Ireland launch of ACUVUE® OASYS MAX 1-Day MULTIFOCAL for ASTIGMATISM by Johnson & Johnson Vision marks a significant development, as it becomes the first daily disposable multifocal toric lens to address this challenge. The lens aims to enhance visual performance across distances, with a reported 91% initial fitting success rate.
1. Astigmatism affects nearly half of patients. 2. Presbyopia will affect 2.1 billion people by 2030. 3. Johnson & Johnson launched ACUVUE® OASYS MAX 1-Day MULTIFOCAL for ASTIGMATISM in the UK and Ireland. 4. The lens aims to support vision across multiple distances. 5. The fit success rate is 91% on first visit. 6. New fitting tools are introduced to aid practitioners. 7. Broader rollout is set for spring 2026.